Structural and Evolutionary Dynamics of Influenza A Hemagglutinin Receptor-Binding Site: A Computational Approach to Predicting Host Tropism and Pandemic Potential

Introduction

Influenza A viruses (IAVs) circulate widely in avian and swine populations, posing continuous zoonotic threats to mammalian hosts [1, 2]. The hemagglutinin (HA) glycoprotein mediates viral entry by binding to terminal sialic acid (SA) receptors on host epithelial cells [3]. The receptor-binding site (RBS) located in the globular head of HA1 determines specificity for SA linked via α2,3 or α2,6 glycosidic bonds to galactose [4]. Avian IAVs typically bind α2,3-linked SA, whereas mammalian-adapted viruses preferentially recognize α2,6-linked SA [3, 4]. Swine respiratory epithelium expresses both linkage types, making pigs a key intermediate host for reassortment and adaptation [2]. Computational approaches that integrate structural modeling, molecular dynamics (MD) simulations, and phylogenetic analysis have become essential for predicting host tropism shifts and assessing pandemic potential from sequence data alone [1, 5, 6].

Structural Basis of the Hemagglutinin Receptor-Binding Site

The HA RBS is formed by three structural elements: the 190-helix (residues 188–198), the 130-loop (residues 134–138), and the 220-loop (residues 221–228) [3]. These segments create a shallow pocket that accommodates the terminal sialic acid moiety of the host glycan receptor [4]. Conserved residues within these elements, including Tyr98, Trp153, His183, and Tyr195 (H3 numbering), form direct hydrogen bonds with the sialic acid carboxylate and glycerol groups [4, 6]. The specificity for α2,3 versus α2,6 linkages is governed largely by amino acids at positions 226 and 228 (H3 numbering) within the 220-loop [5, 4]. In avian-adapted HAs, Gln226 and Gly228 are predominant, while mammalian-adapted HAs often carry Leu226 and Ser228 [3, 5]. Position 190 and 225 further modulate binding preference through interactions with the penultimate galactose and the glycosidic linkage [3, 4].

The structural plasticity of the RBS allows single amino acid substitutions to markedly alter receptor preference [5]. For example, the Q226L substitution in H9 and H2 subtypes shifts specificity toward α2,6-linked SA and enhances replication in mammalian models [5]. Conversely, mutations at position 190 from Glu to Asp can reduce α2,6 binding affinity while retaining α2,3 recognition [3, 6]. Carlock and Ross [3] reviewed how the HA1 globular head undergoes antigenic drift while the HA2 stem remains conserved, highlighting the evolutionary flexibility of the RBS under immune pressure.

Key Mutations and Host Tropism Shifts

Position 226 (H3 Numbering)

The role of residue 226 in receptor specificity has been extensively characterized across multiple subtypes [1, 5]. Ivan et al. [1] demonstrated that clinical isolates from Singapore harbored HA sequences with both Q226 and L226, correlating with differential receptor binding in vitro. Obadan et al. [5] systematically replaced residue 226 in an H9 HA with all 20 amino acids and assessed viability, receptor binding, and in vivo fitness in quail. They found that many substitutions (e.g., Met, Ile, Val, Phe) were tolerated and allowed simultaneous recognition of α2,3- and α2,6-linked SA, a phenotype associated with increased pandemic risk [5]. This flexibility suggests that surveillance efforts should not focus solely on the Q226L change but must consider a broader mutational space.

Positions 190, 225, and 228

The 190-helix residue Glu190 (in H1 and H3 subtypes) forms a hydrogen bond with the sialic acid N-acetyl group; substitution to Asp190 alters the binding angle and reduces preference for α2,6 receptors [4, 6]. Position 225 (Gly225 in avian strains, Asp225 in human-adapted H1) influences the conformation of the 220-loop and the orientation of the galactose ring [6]. In the 1918 pandemic H1 HA (SC18), Elli et al. [6] used nuclear magnetic resonance (NMR) and MD simulations to show that human-adapted HA imposes stringent conformational constraints on the human glycan receptor LSTc, a property absent in avian-adapted variants. The combination of D225 and L226 in human H1 provides a characteristic NMR signature for human adaptation [6]. Position 228 (Gly228 in avian, Ser228 in mammalian) supports the 220-loop conformation required for α2,6 binding in H2 and H3 subtypes [3].

Subtype-Specific Patterns

Lebarbenchon and Stallknecht [2] examined H7 HA evolution and found that host shifts from wild waterfowl to poultry and then to mammals were accompanied by sequential mutations in the RBS, including N158D and A138V, that increased binding to α2,6 receptors. These mutations did not always occur in the same order, indicating multiple evolutionary pathways to mammalian adaptation [2]. The H5 and H9 subtypes also exhibit convergent evolution at position 226 [1, 3, 5].

Computational Approaches for Predicting Host Tropism

Molecular Dynamics Simulations

MD simulations provide atomic-level insight into HA-glycan interactions over nanosecond to microsecond timescales [4, 6]. Priyadarzini et al. [4] performed 10 ns MD simulations on H1, H3, H5, and H9 HA complexes with α2,3- and α2,6-linked sialyldisaccharides. They analyzed glycosidic torsional angles, hydrogen bonding networks, and pair interaction energies to rank binding specificity. The order for α2,3 specificity was H3 > H5 > H9 > H1; for α2,6, the order was H1 > H3 > H5 > H9 [4]. These rankings correlate with known host tropism: H1 (human-adapted) prefers α2,6, while H5 (avian) prefers α2,3. Elli et al. [6] extended MD simulations to 100 ns and incorporated NMR constraints, demonstrating that human-adapted HAs restrict the conformational space of the bound glycan more than avian-adapted HAs.

Binding Free Energy Calculations (MM-PBSA/MM-GBSA)

The Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) and Generalized Born Surface Area (MM-GBSA) methods estimate binding free energies from MD trajectories [4]. Priyadarzini et al. [4] used MM-PBSA to compute interaction energies for each HA-glycan complex; they found that energy differences of approximately 2.5 kcal/mol distinguished specific from non-specific binding. Such calculations can predict the effect of single mutations (e.g., Q226L, E190D) on receptor preference in silico, potentially reducing the need for extensive wet-lab screening [5, 4].

Homology Modeling and Molecular Docking

When experimental structures are unavailable, homology modeling using templates from the [Protein Data Bank](/knowledge/bioinformatics/protein-data-bank-formats-archival-validation 2) (PDB) builds three-dimensional HA models [3, 4]. Docking algorithms (e.g., AutoDock Vina, Glide) place SA glycans into the RBS and score binding poses [6]. These approaches allow rapid screening of sequence variants from public databases such as GISAID and the NCBI Influenza Virus Resource [1, 2]. Combined with phylogenetic analysis, they can identify emerging lineages with altered receptor specificity before phenotypic data are generated [1, 5].

Phylogenetic and Sequence Surveillance

Phylogenetic reconstruction of HA sequences from avian, swine, and human isolates reveals clades associated with host shifts [2, 3]. Ivan et al. [1] combined phylogenetic analysis with in vitro receptor binding assays to track the emergence of Q226L in H9N2 viruses in Southeast Asia. Lebarbenchon and Stallknecht [2] used phylogeographic methods to map H7 evolution from wild birds to poultry and detected recurring mutations at positions 138 and 158 that correlated with α2,6 binding.

Integrated Computational Workflow

A comprehensive pipeline for predicting host tropism from HA sequences integrates these computational methods. The following Mermaid diagram illustrates a typical workflow.

flowchart TD
    A[HA sequence from GISAID/NCBI], > B[Multiple sequence alignment & phylogenetic analysis]
    B, > C{Avian or mammalian clade?}
    C, >|Avian| D[Homology model (avian template)]
    C, >|Mammalian| E[Homology model (mammalian template)]
    D, > F[Molecular dynamics simulation with α2,3 glycan]
    E, > G[Molecular dynamics simulation with α2,6 glycan]
    F, > H[MM-PBSA/GBSA binding free energy calculation]
    G, > H
    H, > I[Receptor specificity score]
    I, > J{Energy difference < threshold?}
    J, >|Yes| K[Predicted dual/tripartite receptor binding]
    J, >|No| L[Predicted avian-specific or mammalian-specific binding]
    K, > M[Pandemic risk flag: high]
    L, > N[Pandemic risk flag: low]

Phylogenetic clustering informs template selection for homology modeling. MD simulations are performed with both α2,3- and α2,6-linked glycans (e.g., Neu5Acα2-3Galβ1-4Glc and Neu5Acα2-6Galβ1-4Glc) [4]. MM-PBSA calculations provide binding free energies; a small difference (e.g., <2.5 kcal/mol) between the two receptors suggests dual binding, a hallmark of pandemic potential [5, 4]. Such pipelines are increasingly automated and can be applied to large-scale surveillance datasets.

Case Study: H9N2 Receptor Binding Plasticity

Obadan et al. [5] exemplify the combined use of experimental and computational approaches. They created a saturation mutagenesis library at HA residue 226 in an H9 subtype. Variants carrying Q226, L226, M226, I226, or V226 were viable and displayed mixed receptor specificity. MD simulations (referenced in [5]) suggested that larger hydrophobic residues at position 226 widen the 220-loop, allowing both α2,3 and α2,6 glycans to adopt favorable conformations. In vivo studies in quail confirmed that some dual-binding variants replicated efficiently and transmitted among birds, underscoring the utility of computational predictions for surveillance prioritization [5].

Cross-Linking to Related Resources

The computational analysis of HA RBS dynamics is closely related to broader topics in viral glycoprotein evolution and zoonotic risk assessment. Readers may consult the existing article Zoonotic Spillover Pathways and Receptor Binding Evolution in Bat Reservoirs for comparative insights into receptor binding evolution in bat-borne viruses. Additionally, the portal provides dedicated resources such as Computational Structural Virology of Avian Influenza Hemagglutinin: Predicting Host Range and Pandemic Potential and Structural Dynamics of Avian Influenza Hemagglutinin: Molecular Modeling and Receptor Binding Predictions for Pandemic Risk Assessment. The broader framework of Machine Learning-Driven Prediction of Antigenic Drift in Influenza A Hemagglutinin complements the structural focus presented here.

Implications for Pandemic Surveillance in Veterinary Populations

Surveillance of IAVs in poultry and swine is critical for early detection of strains with pandemic potential [1, 2]. Computational tools enable rapid triage of field sequences: sequences encoding L226, S228, D190, or D225 can be flagged for further experimental characterization [3, 5]. The plasticity of residue 226, as demonstrated by Obadan et al. [5], suggests that surveillance alerts should not be limited to a single amino acid change but should incorporate structural modeling predictions of dual receptor binding. Furthermore, the integration of NMR-derived conformational constraints, as shown by Elli et al. [6], can improve the accuracy of MD-based predictions, particularly for detecting subtle shifts in glycan conformation that correlate with mammalian adaptation. Veterinary diagnostic laboratories can incorporate these computational pipelines into their bioinformatics workflows for routine risk assessment.

Conclusion

The influenza A HA receptor-binding site is a dynamic structural element whose sequence variations tightly control host tropism. Computational methods, including MD simulations, MM-PBSA binding free energy calculations, homology modeling, and phylogenetic analysis, offer powerful means to predict receptor specificity from sequence data alone. Key mutations at positions 226, 228, 190, and 225 have been well characterized across multiple subtypes, and the flexibility of these positions suggests that multiple mutational pathways can lead to increased pandemic potential. Continued integration of computational predictions with in vitro and in vivo assays will strengthen surveillance programs in avian and swine populations, ultimately informing pandemic preparedness strategies.

References

[1] Ivan FX, Zhou X, Lau SH, et al. Molecular insights into evolution, mutations and receptor-binding specificity of influenza A and B viruses from outpatients and hospitalized patients in Singapore. Int J Infect Dis. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/31669593/

[2] Lebarbenchon C, Stallknecht DE. Host shifts and molecular evolution of H7 avian influenza virus hemagglutinin. Virol J. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21711553/

[3] Carlock M, Ross TM. The evolution of influenza hemagglutinin: structural numbering and receptor binding sites of influenza viruses capable of infecting humans. Frontiers in Virology. 2026. URL: https://www.semanticscholar.org/paper/cc213413387f3440c1f36162d86e4d205e60168b

[4] Priyadarzini TRK, Selvin JFA, Gromiha M, et al. Theoretical Investigation on the Binding Specificity of Sialyldisaccharides with Hemagglutinins of Influenza A Virus by Molecular Dynamics Simulations. Journal of Biological Chemistry. 2012. URL: https://www.semanticscholar.org/paper/1d0dbbd33b1d99b1b291d6b211025c3bdf91e5c9

[5] Obadan AO, Santos JJS, Ferreri L, et al. Flexibility In Vitro of Amino Acid 226 in the Receptor-Binding Site of an H9 Subtype Influenza A Virus and Its Effect In Vivo on Virus Replication, Tropism, and Transmission. Journal of Virology. 2018. URL: https://www.semanticscholar.org/paper/43e5a06877baf6ab88fb36743277adbc31e7f264

[6] Elli S, Macchi E, Rudd T, et al. Insights into the Human Glycan Receptor Conformation of 1918 Pandemic Hemagglutinin–Glycan Complexes Derived from Nuclear Magnetic Resonance and Molecular Dynamics Studies. Biochemistry. 2014. URL: https://www.semanticscholar.org/paper/9806af38203074d1178eb0377af5f4ad11f00814 *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.